{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:52:57Z","timestamp":1761598377923,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603641","81704098","81774339","82074462"],"award-info":[{"award-number":["81603641","81704098","81774339","82074462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["XK201912"],"award-info":[{"award-number":["XK201912"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20201318"],"award-info":[{"award-number":["20201318"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2017A020213030"],"award-info":[{"award-number":["2017A020213030"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108177","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:34:10Z","timestamp":1633649650000},"page":"108177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"PA","title":["12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation"],"prefix":"10.1016","volume":"101","author":[{"given":"Delong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiake","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.intimp.2021.108177_b0005","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/ajmg.a.31368","article-title":"The new bone biology: pathologic, molecular, and clinical correlates","volume":"140","author":"Cohen","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"6882","key":"10.1016\/j.intimp.2021.108177_b0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/416686a","article-title":"Medicine: interfering with bone remodelling","volume":"416","author":"Alliston","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2021.108177_b0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.2017-00064","article-title":"Energy Metabolism of the Osteoblast: Implications for Osteoporosis","volume":"38","author":"Lee","year":"2017","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.intimp.2021.108177_b0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ptj\/86.1.77","article-title":"Bone biology and the clinical implications for osteoporosis","volume":"86","author":"Downey","year":"2006","journal-title":"Phys Ther"},{"key":"10.1016\/j.intimp.2021.108177_b0025","article-title":"Bisphosphonates for the prevention and treatment of osteoporosis","volume":"351","author":"Maraka","year":"2015","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.intimp.2021.108177_b0030","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1002\/jcp.26465","article-title":"Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?","volume":"233","author":"Vargas-Franco","year":"2018","journal-title":"J Cell Physiol"},{"issue":"9","key":"10.1016\/j.intimp.2021.108177_b0035","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2174\/1389450118666170321105425","article-title":"Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis","volume":"18","author":"Wang","year":"2017","journal-title":"Curr Drug Targets"},{"issue":"6937","key":"10.1016\/j.intimp.2021.108177_b0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"5484","key":"10.1016\/j.intimp.2021.108177_b0045","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.intimp.2021.108177_b0050","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.intimp.2021.108177_b0055","first-page":"66","article-title":"Modulation of osteoclast differentiation","volume":"13","author":"SUDA","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1016\/j.intimp.2021.108177_b0060","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.omtn.2021.01.031","article-title":"Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1","volume":"23","author":"Liang","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"10.1016\/j.intimp.2021.108177_b0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14737140.7.2.221","article-title":"Key roles of the OPG-RANK-RANKL system in bone oncology","volume":"7","author":"Baud\u2019huin","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.intimp.2021.108177_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4068\/cmj.2016.52.1.12","article-title":"Signaling Pathways in Osteoclast Differentiation","volume":"52","author":"Kim","year":"2016","journal-title":"Chonnam Med J"},{"issue":"6","key":"10.1016\/j.intimp.2021.108177_b0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"issue":"2","key":"10.1016\/j.intimp.2021.108177_b0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"issue":"21","key":"10.1016\/j.intimp.2021.108177_b0085","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.1074\/jbc.M901670200","article-title":"Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis","volume":"284","author":"Feng","year":"2009","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.intimp.2021.108177_b0090","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/jm00089a006","article-title":"A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1","volume":"35","author":"Gustafson","year":"1992","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.intimp.2021.108177_b0095","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.canlet.2014.10.018","article-title":"The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents","volume":"356","author":"Shen","year":"2015","journal-title":"Cancer Lett."},{"issue":"40","key":"10.1016\/j.intimp.2021.108177_b0100","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.1074\/jbc.M402124200","article-title":"Prostratin antagonizes HIV latency by activating NF-kappaB","volume":"279","author":"Williams","year":"2004","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.intimp.2021.108177_b0105","doi-asserted-by":"crossref","first-page":"e48832","DOI":"10.1371\/journal.pone.0048832","article-title":"Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB","volume":"7","author":"Ying","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.intimp.2021.108177_b0110","first-page":"2507","article-title":"Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin","volume":"53","author":"Szallasi","year":"1993","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.intimp.2021.108177_b0115","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/carcin\/13.11.2161","article-title":"Non-promoting 12-deoxyphorbol 13-esters as potent inhibitors of phorbol 12-myristate 13-acetate-induced acute and chronic biological responses in CD-1 mouse skin","volume":"13","author":"Szallasi","year":"1992","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.intimp.2021.108177_b0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/BJ20121626","article-title":"HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors","volume":"451","author":"Kraan","year":"2013","journal-title":"Biochem J"},{"issue":"12","key":"10.1016\/j.intimp.2021.108177_b0125","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An overview of the regulation of bone remodelling at the cellular level","volume":"45","author":"Kular","year":"2012","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.intimp.2021.108177_b0130","first-page":"113","article-title":"Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility","volume":"12","author":"McCormick","year":"2007","journal-title":"Altern Med Rev"},{"issue":"5","key":"10.1016\/j.intimp.2021.108177_b0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines, and bone remodeling Emerging insights into the pathophysiology of osteoporosis","volume":"332","author":"Epstein","year":"1995","journal-title":"N Engl J Med"},{"issue":"9773","key":"10.1016\/j.intimp.2021.108177_b0140","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.108177_b0145","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2012.13624","article-title":"The future of osteoporosis treatment - a research update","volume":"142","author":"Lippuner","year":"2012","journal-title":"Swiss Med Wkly"},{"issue":"22","key":"10.1016\/j.intimp.2021.108177_b0150","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1056\/NEJMp1202623","article-title":"Continuing bisphosphonate treatment for osteoporosis\u2013for whom and for how long?","volume":"366","author":"Black","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.intimp.2021.108177_b0155","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.2196\/resprot.7636","article-title":"Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical Study","volume":"6","author":"Deng","year":"2017","journal-title":"JMIR Res Protoc"},{"issue":"8","key":"10.1016\/j.intimp.2021.108177_b0160","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/jbmr.4025","article-title":"Hymenialdisine: a marine natural product that acts on both osteoblasts and osteoclasts and prevents estrogen-dependent bone loss in mice","volume":"35","author":"Wang","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.intimp.2021.108177_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104944","article-title":"Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation","volume":"159","author":"Chen","year":"2020","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.intimp.2021.108177_b0170","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.7150\/thno.30206","article-title":"Pseurotin A inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.intimp.2021.108177_b0175","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.intimp.2021.108177_b0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI200419657","article-title":"Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation","volume":"114","author":"Ikeda","year":"2004","journal-title":"J Clin Invest"},{"issue":"42","key":"10.1016\/j.intimp.2021.108177_b0185","doi-asserted-by":"crossref","first-page":"35081","DOI":"10.1074\/jbc.C500353200","article-title":"Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1","volume":"280","author":"Monje","year":"2005","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.intimp.2021.108177_b0190","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.cdd.4401882","article-title":"Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL","volume":"13","author":"Huang","year":"2006","journal-title":"Cell Death Differ"},{"issue":"11","key":"10.1016\/j.intimp.2021.108177_b0195","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1172\/JCI35711","article-title":"NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism","volume":"118","author":"Aliprantis","year":"2008","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.intimp.2021.108177_b0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gene.2009.06.013","article-title":"Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand","volume":"446","author":"Balkan","year":"2009","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.intimp.2021.108177_b0205","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol Cells"},{"key":"10.1016\/j.intimp.2021.108177_b0210","doi-asserted-by":"crossref","first-page":"45964","DOI":"10.1038\/srep45964","article-title":"p38alpha MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner","volume":"7","author":"Cong","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.intimp.2021.108177_b0215","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1073\/pnas.0406874102","article-title":"Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium\/calcineurin\/NFAT pathway in osteoclasts","volume":"102","author":"Komarova","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.intimp.2021.108177_b0220","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbamcr.2010.11.002","article-title":"Calcium signaling in osteoclasts","volume":"1813","author":"Hwang","year":"2011","journal-title":"Biochim Biophys Acta"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:39:08Z","timestamp":1761586748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921008134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"alternative-id":["S1567576921008134"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108177","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108177"}}